{"entity":{"type":"insider","cik":"0001710625","url":"/insider/0001710625","json_url":"/insider/0001710625.json","name":"Lemercier Jean-Luc M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":24,"first":"2018-03-08","last":"2024-05-01","span_basis":"filed_date"},"name_variants":[{"name":"Lemercier Jean-Luc M","source":"filing","n_filings":24,"first_seen":"2018-03-08","last_seen":"2024-05-01"}],"transactions":[{"id":2322304,"accession":"0001225208-24-005437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-24-005437","line_url":"/filing/0001225208-24-005437","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA and JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA and JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA and JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14400.0,"shares_display":"14,400","price_per_share":84.21438,"price_display":"84.21","price_state":"stated","total_value":1212687.072,"total_display":"1,212,687.07","total_whole":"1,212,687","shares_owned_after":173848.8055,"shares_owned_after_display":"173,848.81","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-01","scope":"insider","n_lines":2},{"id":3078835,"accession":"0001225208-24-005005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-24-005005","line_url":"/filing/0001225208-24-005005","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14400.0,"shares_display":"14,400","price_per_share":92.32443722222222,"price_display":"92.32","price_state":"stated","total_value":1329471.896,"total_display":"1,329,471.90","total_whole":"1,329,472","shares_owned_after":173848.8055,"shares_owned_after_display":"173,848.81","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-08","scope":"insider","n_lines":2},{"id":3248934,"accession":"0001225208-24-004035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-004035","line_url":"/filing/0001225208-24-004035#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA and JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA and JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA and JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14400.0,"shares_display":"14,400","price_per_share":91.677,"price_display":"91.68","price_state":"stated","total_value":1320148.8,"total_display":"1,320,148.80","total_whole":"1,320,149","shares_owned_after":173583.7785,"shares_owned_after_display":"173,583.78","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-11","scope":"insider"},{"id":8476776,"accession":"0001225208-23-005617","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-23-005617","line_url":"/filing/0001225208-23-005617#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA and JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA and JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA and JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6640.0,"shares_display":"6,640","price_per_share":88.68,"price_display":"88.68","price_state":"stated","total_value":588835.2,"total_display":"588,835.20","total_whole":"588,835","shares_owned_after":172089.7785,"shares_owned_after_display":"172,089.78","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-09","scope":"insider"},{"id":8755097,"accession":"0001225208-23-004761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-004761","line_url":"/filing/0001225208-23-004761#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA and JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA and JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA and JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6640.0,"shares_display":"6,640","price_per_share":83.0973,"price_display":"83.10","price_state":"stated","total_value":551766.072,"total_display":"551,766.07","total_whole":"551,766","shares_owned_after":169137.7785,"shares_owned_after_display":"169,137.78","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-06","scope":"insider"},{"id":7956595,"accession":"0001225208-23-003597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-23-003597","line_url":"/filing/0001225208-23-003597","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEACLA and JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, EMEACLA and JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEACLA and JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6640.0,"shares_display":"6,640","price_per_share":76.95728659638554,"price_display":"76.96","price_state":"stated","total_value":510996.383,"total_display":"510,996.38","total_whole":"510,996","shares_owned_after":168874.8696,"shares_owned_after_display":"168,874.87","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6219867,"accession":"0001225208-22-006814","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-22-006814","line_url":"/filing/0001225208-22-006814#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11560.0,"shares_display":"11,560","price_per_share":98.2447,"price_display":"98.24","price_state":"stated","total_value":1135708.732,"total_display":"1,135,708.73","total_whole":"1,135,709","shares_owned_after":162899.3402,"shares_owned_after_display":"162,899.34","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-10","scope":"insider"},{"id":6965100,"accession":"0001225208-22-005750","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-22-005750","line_url":"/filing/0001225208-22-005750","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11660.0,"shares_display":"11,660","price_per_share":123.29517735849056,"price_display":"123.30","price_state":"stated","total_value":1437621.768,"total_display":"1,437,621.77","total_whole":"1,437,622","shares_owned_after":152326.3402,"shares_owned_after_display":"152,326.34","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-11","scope":"insider","n_lines":2},{"id":6526623,"accession":"0001225208-22-004574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-22-004574","line_url":"/filing/0001225208-22-004574","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11660.0,"shares_display":"11,660","price_per_share":106.00956303602058,"price_display":"106.01","price_state":"stated","total_value":1236071.505,"total_display":"1,236,071.50","total_whole":"1,236,072","shares_owned_after":152103.487,"shares_owned_after_display":"152,103.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-11","scope":"insider","n_lines":2},{"id":5065046,"accession":"0001225208-21-014184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-014184","line_url":"/filing/0001225208-21-014184#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":110.58,"price_display":"110.58","price_state":"stated","total_value":11058.0,"total_display":"11,058.00","total_whole":"11,058","shares_owned_after":152103.487,"shares_owned_after_display":"152,103.49","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-29","scope":"insider"},{"id":5439127,"accession":"0001225208-21-006242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-006242","line_url":"/filing/0001225208-21-006242#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13020.0,"shares_display":"13,020","price_per_share":83.6608,"price_display":"83.66","price_state":"stated","total_value":1089263.616,"total_display":"1,089,263.62","total_whole":"1,089,264","shares_owned_after":139541.138,"shares_owned_after_display":"139,541.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-01","scope":"insider"},{"id":4346554,"accession":"0001225208-21-004099","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-21-004099","line_url":"/filing/0001225208-21-004099","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13020.0,"shares_display":"13,020","price_per_share":84.72065867895546,"price_display":"84.72","price_state":"stated","total_value":1103062.976,"total_display":"1,103,062.98","total_whole":"1,103,063","shares_owned_after":139220.7448,"shares_owned_after_display":"139,220.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-01","scope":"insider","n_lines":2},{"id":4688816,"accession":"0001225208-21-001360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-21-001360","line_url":"/filing/0001225208-21-001360#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20523.0,"shares_display":"20,523","price_per_share":83.5057,"price_display":"83.51","price_state":"stated","total_value":1713787.4811,"total_display":"1,713,787.48","total_whole":"1,713,787","shares_owned_after":139220.7448,"shares_owned_after_display":"139,220.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-01","scope":"insider"},{"id":4346119,"accession":"0001225208-21-000102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-21-000102","line_url":"/filing/0001225208-21-000102#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20523.0,"shares_display":"20,523","price_per_share":91.2379,"price_display":"91.24","price_state":"stated","total_value":1872475.4217,"total_display":"1,872,475.42","total_whole":"1,872,475","shares_owned_after":139220.7448,"shares_owned_after_display":"139,220.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-04","scope":"insider"},{"id":3133914,"accession":"0001225208-20-006773","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-006773","line_url":"/filing/0001225208-20-006773#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3470.0,"shares_display":"3,470","price_per_share":223.5,"price_display":"223.50","price_state":"stated","total_value":775545.0,"total_display":"775,545.00","total_whole":"775,545","shares_owned_after":41931.0477,"shares_owned_after_display":"41,931.05","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-27","scope":"insider"},{"id":3021454,"accession":"0001225208-20-005797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-005797","line_url":"/filing/0001225208-20-005797#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3470.0,"shares_display":"3,470","price_per_share":180.84,"price_display":"180.84","price_state":"stated","total_value":627514.8,"total_display":"627,514.80","total_whole":"627,515","shares_owned_after":41931.0477,"shares_owned_after_display":"41,931.05","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-01","filed_date":"2020-04-01","scope":"insider"},{"id":3327135,"accession":"0001225208-20-003736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-003736","line_url":"/filing/0001225208-20-003736#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3470.0,"shares_display":"3,470","price_per_share":217.53,"price_display":"217.53","price_state":"stated","total_value":754829.1,"total_display":"754,829.10","total_whole":"754,829","shares_owned_after":41817.5844,"shares_owned_after_display":"41,817.58","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-02-27","scope":"insider"},{"id":2194937,"accession":"0001225208-20-001529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-001529","line_url":"/filing/0001225208-20-001529#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3470.0,"shares_display":"3,470","price_per_share":219.5,"price_display":"219.50","price_state":"stated","total_value":761665.0,"total_display":"761,665.00","total_whole":"761,665","shares_owned_after":41817.5844,"shares_owned_after_display":"41,817.58","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-03","scope":"insider"},{"id":8718715,"accession":"0001510192-19-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001510192-19-000051","line_url":"/filing/0001510192-19-000051#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Ameri)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Ameri)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Ameri","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4188.0,"shares_display":"4,188","price_per_share":176.17,"price_display":"176.17","price_state":"stated","total_value":737799.96,"total_display":"737,799.96","total_whole":"737,800","shares_owned_after":40409.8535,"shares_owned_after_display":"40,409.85","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-06","filed_date":"2019-05-07","scope":"insider"},{"id":8764794,"accession":"0001225208-19-006591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-006591","line_url":"/filing/0001225208-19-006591#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4186.0,"shares_display":"4,186","price_per_share":188.23,"price_display":"188.23","price_state":"stated","total_value":787930.78,"total_display":"787,930.78","total_whole":"787,931","shares_owned_after":40409.8535,"shares_owned_after_display":"40,409.85","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-09","scope":"insider"},{"id":8302082,"accession":"0001225208-19-005776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-005776","line_url":"/filing/0001225208-19-005776#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4186.0,"shares_display":"4,186","price_per_share":188.6,"price_display":"188.60","price_state":"stated","total_value":789479.6,"total_display":"789,479.60","total_whole":"789,480","shares_owned_after":40409.8535,"shares_owned_after_display":"40,409.85","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-25","filed_date":"2019-03-25","scope":"insider"},{"id":6297801,"accession":"0001225208-18-009119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-18-009119","line_url":"/filing/0001225208-18-009119#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5634.0,"shares_display":"5,634","price_per_share":134.91,"price_display":"134.91","price_state":"stated","total_value":760082.94,"total_display":"760,082.94","total_whole":"760,083","shares_owned_after":38784.0233,"shares_owned_after_display":"38,784.02","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-09","filed_date":"2018-05-10","scope":"insider"},{"id":6276476,"accession":"0001225208-18-007725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-18-007725","line_url":"/filing/0001225208-18-007725#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5633.0,"shares_display":"5,633","price_per_share":139.42,"price_display":"139.42","price_state":"stated","total_value":785352.86,"total_display":"785,352.86","total_whole":"785,353","shares_owned_after":38840.0233,"shares_owned_after_display":"38,840.02","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-11","filed_date":"2018-04-12","scope":"insider"},{"id":6561839,"accession":"0001225208-18-005784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-18-005784","line_url":"/filing/0001225208-18-005784#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001710625","owner_name":"Lemercier Jean-Luc M","owner_display_name":"Lemercier Jean-Luc M","owner_url":"/insider/0001710625","role":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark":"O","role_mark_label":"Officer (CVP, EMEA, Canada, Latin Amer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, EMEA, Canada, Latin Amer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5633.0,"shares_display":"5,633","price_per_share":136.29,"price_display":"136.29","price_state":"stated","total_value":767721.57,"total_display":"767,721.57","total_whole":"767,722","shares_owned_after":38665.4191,"shares_owned_after_display":"38,665.42","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Officer (CVP, EMEACLA and JAPAC)","n_filings":24,"first_seen":"2018-03-08","last_seen":"2024-05-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001710625","retrieved_at":"2026-08-27T09:29:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}